INVESTIGATION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA BY MOLECULAR ANALYSIS

This publication has 142 references indexed in Scilit:

• Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
  The Lancet, 1998
• Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR
  British Journal of Haematology, 1998
• Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemia
  British Journal of Haematology, 1997
• The majority of myeloid‐antigen‐positive (My⁺) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts
  British Journal of Haematology, 1997
• Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA
  British Journal of Haematology, 1997
• Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clonespecific or malignancy-specific gene markers
  Cancer Genetics and Cytogenetics, 1996
• In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: Implications for autologous BMT
  Annals of Hematology, 1994
• The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
  Cell, 1992
• Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
  Cell, 1992
• DISCREPANCY OF BONE-MARROW ASPIRATIONS IN ACUTE LYMPHOBLASTIC LEUKÆMIA IN RELAPSE
  The Lancet, 1977